I obtained my PhD in Molecular Biology at Imperial College, London, before moving on to postdoctoral positions in Australia.永利皇冠app

My background is in genetics and gene therapy – I first identified the genes required for development of the Drosophila brain and then generated one of the first mouse models of cystic fibrosis with the same mutation as found in humans. This was followed by work on gene therapy for cystic fibrosis in a collaboration between Boehringer Ingelheim and the Medical Research Council (MRC) Human Genetics Unit in Edinburgh.

I joined AstraZeneca as a 团队 Leader in 1997 and since then, have provided support for many drug discovery projects around target identification, validation and reagent generation. I have also been a project leader for several small molecule and biologics project 团队s. In 2002, I became a Principal Scientist and in 2011 moved to Gothenburg where I have led 团队s carrying out target validation and biomarker discovery.